TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,634,992 | -69.0% | 1,152,511 | -7.8% | 0.00% | -50.0% |
| Q2 2023 | $31,039,294 | +11.2% | 1,249,569 | -32.7% | 0.01% | 0.0% |
| Q1 2023 | $27,904,389 | +23.0% | 1,855,345 | -3.2% | 0.01% | 0.0% |
| Q4 2022 | $22,678,110 | +39.4% | 1,917,000 | -30.3% | 0.01% | +100.0% |
| Q3 2022 | $16,272,000 | +35.2% | 2,748,575 | -3.0% | 0.00% | 0.0% |
| Q2 2022 | $12,037,000 | -40.4% | 2,832,444 | +33.4% | 0.00% | -25.0% |
| Q1 2022 | $20,189,000 | +72.3% | 2,123,028 | +244.2% | 0.00% | +33.3% |
| Q4 2021 | $11,718,000 | -43.5% | 616,721 | -1.0% | 0.00% | -25.0% |
| Q3 2021 | $20,735,000 | +19.8% | 623,033 | +39.6% | 0.00% | 0.0% |
| Q2 2021 | $17,308,000 | -23.5% | 446,225 | -4.9% | 0.00% | -33.3% |
| Q1 2021 | $22,617,000 | -67.6% | 469,237 | -65.0% | 0.01% | -66.7% |
| Q4 2020 | $69,753,000 | +139.5% | 1,340,866 | +23.2% | 0.02% | +125.0% |
| Q3 2020 | $29,128,000 | +56.9% | 1,088,512 | +14.2% | 0.01% | +14.3% |
| Q2 2020 | $18,562,000 | -32.1% | 952,881 | -65.7% | 0.01% | -46.2% |
| Q1 2020 | $27,331,000 | +90.9% | 2,777,517 | +115.4% | 0.01% | +116.7% |
| Q4 2019 | $14,316,000 | +250.0% | 1,289,681 | +77.0% | 0.01% | +200.0% |
| Q3 2019 | $4,090,000 | +14.3% | 728,491 | +76.1% | 0.00% | +100.0% |
| Q2 2019 | $3,579,000 | +48.9% | 413,724 | +38.3% | 0.00% | 0.0% |
| Q1 2019 | $2,404,000 | -19.8% | 299,075 | -59.1% | 0.00% | 0.0% |
| Q4 2018 | $2,998,000 | -53.4% | 731,188 | -36.3% | 0.00% | -66.7% |
| Q3 2018 | $6,430,000 | -8.2% | 1,148,346 | +115.6% | 0.00% | 0.0% |
| Q2 2018 | $7,006,000 | +7.0% | 532,749 | +15.6% | 0.00% | 0.0% |
| Q1 2018 | $6,545,000 | +123.5% | 460,915 | +29.1% | 0.00% | 0.0% |
| Q4 2017 | $2,928,000 | -6.8% | 357,046 | +34.8% | 0.00% | 0.0% |
| Q3 2017 | $3,140,000 | +4.6% | 264,965 | -11.3% | 0.00% | 0.0% |
| Q2 2017 | $3,002,000 | +2.5% | 298,701 | +18.7% | 0.00% | 0.0% |
| Q1 2017 | $2,930,000 | +5534.6% | 251,538 | +2166.1% | 0.00% | – |
| Q4 2016 | $52,000 | -87.5% | 11,100 | -79.3% | 0.00% | – |
| Q3 2016 | $415,000 | +55.4% | 53,512 | +21.6% | 0.00% | – |
| Q2 2016 | $267,000 | -28.6% | 44,001 | +40.2% | 0.00% | – |
| Q4 2015 | $374,000 | +71.6% | 31,383 | +45.1% | 0.00% | – |
| Q3 2015 | $218,000 | -63.8% | 21,626 | -40.4% | 0.00% | -100.0% |
| Q2 2015 | $602,000 | -38.9% | 36,307 | -43.0% | 0.00% | 0.0% |
| Q1 2015 | $986,000 | +292.8% | 63,697 | +302.3% | 0.00% | – |
| Q4 2014 | $251,000 | -10.0% | 15,834 | -39.4% | 0.00% | – |
| Q3 2014 | $279,000 | +447.1% | 26,119 | +376.9% | 0.00% | – |
| Q2 2014 | $51,000 | -80.3% | 5,477 | -85.4% | 0.00% | – |
| Q1 2014 | $259,000 | +763.3% | 37,606 | +383.3% | 0.00% | – |
| Q4 2013 | $30,000 | – | 7,781 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |